Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer

por Konstantinopoulos, Panagiotis A., Matulonis, Ursula A.
Publicado 2013

From checkpoint to checkpoint: DNA damage ATR/Chk1 checkpoint signalling elicits PD-L1 immune checkpoint activation

por Mouw, Kent W., Konstantinopoulos, Panagiotis A.
Publicado 2018

PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers

por Lee, Elizabeth K., Konstantinopoulos, Panagiotis A.
Publicado 2020

Morphologic and immunophenotypic evidence of in-situ Kaposi's sarcoma

por Konstantinopoulos, Panagiotis A, Dezube, Bruce J, Pantanowitz, Liron
Publicado 2006

Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation

por Markert, Tahireh, Kolin, David L., Konstantinopoulos, Panagiotis A.
Publicado 2022

The Molecular Basis of Retinoids’ Use in Breast Cancer Chemoprevention

por Karamouzis, Michalis V., Konstantinopoulos, Panagiotis A., Papavassiliou, Athanasios G.
Publicado 2007

Nucleotide excision repair (NER) alterations as evolving biomarkers and therapeutic targets in epithelial cancers

por Mouw, Kent W., D’Andrea, Alan D., Konstantinopoulos, Panagiotis A.
Publicado 2015

Durable remission in a patient with ERBB2-amplified recurrent mucinous ovarian carcinoma treated with Trastuzumab-Carboplatin-Paclitaxel

por Neil, Alexander J., Muto, Michael G., Kolin, David L., Konstantinopoulos, Panagiotis A.
Publicado 2023

Predicted neoantigen load in non-hypermutated endometrial cancers: Correlation with outcome and tumor-specific genomic alterations

por Shukla, Sachet A., Howitt, Brooke E., Wu, Catherine J., Konstantinopoulos, Panagiotis A.
Publicado 2016

POLE-mutated clear cell cervical cancer associated with in-utero diethylstilbestrol exposure

por Lee, Elizabeth K., Lindeman, Neal I., Matulonis, Ursula A., Konstantinopoulos, Panagiotis A.
Publicado 2019

Targeted Next-Generation Sequencing Reveals Clinically Actionable BRAF and ESR1 Mutations in Low-Grade Serous Ovarian Carcinoma

por Stover, Elizabeth H., Feltmate, Colleen, Berkowitz, Ross S., Lindeman, Neal I., Matulonis, Ursula A., Konstantinopoulos, Panagiotis A.
Publicado 2018

EGF-R is Expressed and AP-1 and NF-κ:B Are Activated in Stromal Myofibroblasts Surrounding Colon Adenocarcinomas Paralleling Expression of COX-2 and VEGF

por Konstantinopoulos, Panagiotis A., Vandoros, Gerasimos P., Karamouzis, Michalis V., Gkermpesi, Maria, Sotiropoulou-Bonikou, Georgia, Papavassiliou, Athanasios G.
Publicado 2007

Carboplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancer

por Konstantinopoulos, Panagiotis A, Fountzilas, Elena, Pillay, Kamana, Zerbini, Luiz F, Libermann, Towia A, Cannistra, Stephen A, Spentzos, Dimitrios
Publicado 2008

Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4

por Guillemette, Shawna, Serra, Ryan W., Peng, Min, Hayes, Janelle A., Konstantinopoulos, Panagiotis A., Green, Michael R., Cantor, Sharon B.
Publicado 2015

Leiomyosarcoma of the Prostate: Case Report and Review of 54 Previously Published Cases

por Vandoros, Gerasimos P., Manolidis, Theodoros, Karamouzis, Michalis V., Gkermpesi, Maria, Lambropoulou, Maria, Papatsoris, Athanasios G., Zachos, Ioannis, Konstantinopoulos, Panagiotis A.
Publicado 2008

Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer

por Penson, Richard T, Ambrosio, Allison J, Whalen, Christin A, Krasner, Carolyn N, Konstantinopoulos, Panagiotis A, Bradley, Charles, Matulonis, Ursula A, Birrer, Michael J
Publicado 2023

Analysis of Multiple Sarcoma Expression Datasets: Implications for Classification, Oncogenic Pathway Activation and Chemotherapy Resistance

por Konstantinopoulos, Panagiotis A., Fountzilas, Elena, Goldsmith, Jeffrey D., Bhasin, Manoj, Pillay, Kamana, Francoeur, Nancy, Libermann, Towia A., Gebhardt, Mark C., Spentzos, Dimitrios
Publicado 2010

Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells

por Choi, Young Eun, Battelli, Chiara, Watson, Jacqueline, Liu, Joyce, Curtis, Jennifer, Morse, Alexander N., Matulonis, Ursula A., Chowdhury, Dipanjan, Konstantinopoulos, Panagiotis A.
Publicado 2014

Genomic Determinants of De Novo Resistance to Immune Checkpoint Blockade in Mismatch Repair–Deficient Endometrial Cancer

por Gulhan, Doga C., Garcia, Elizabeth, Lee, Elizabeth K., Lindemann, Neal I., Liu, Joyce F., Matulonis, Ursula A., Park, Peter J., Konstantinopoulos, Panagiotis A.
Publicado 2020

Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer

por Lee, Elizabeth K., Tan-Wasielewski, Zhenying, Matulonis, Ursula A., Birrer, Michael J., Wright, Alexi A., Horowitz, Neil, Konstantinopoulos, Panagiotis A., Curtis, Jennifer, Liu, Joyce F.
Publicado 2019